Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®
Clinical trial NCT04115488 · COMPLETED
Trial details
- NCT number
- NCT04115488
- Sponsor
- Polpharma Biologics S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-08-23
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.